H

ello, everyone, and how are you this fine morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made is this far, which is a likely sign of surviving another few days. And, of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Hope you conquer the world and, as always, do keep in touch …

Merck (MRK) plans to build a new facility in Dublin on the site of its former women’s health care products business, and create 350 jobs, the Irish Times tells us. The drug maker, which wants to ramp up global manufacturing capacity for its Keytruda cancer therapy, expects the new facility to be operational in 2021 and fully certified by 2022. The company had put the facility on the market last year after it transferred the long-standing women’s health products business from the site to the Netherlands.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.